Androgen Deprivation Therapy (ADT) Clinical Trials
8 recruitingDrug
Phase 25Phase 34Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
AstraZeneca700 enrolled329 locationsNCT06952803
Recruiting
Phase 2
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Prostate Cancer
University of Nebraska140 enrolled1 locationNCT07237269
Recruiting
Phase 2Phase 3
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,600 enrolled1 locationNCT07426094
Recruiting
Phase 2Phase 3
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
Prostate Cancer (Adenocarcinoma)Stereotactic Body Radiation Therapy (SBRT)Localized Prostate Cancer+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,200 enrolled1 locationNCT07426055
Recruiting
Phase 2
Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)
Prostate Cancer
University of Texas Southwestern Medical Center68 enrolled1 locationNCT07313241
Recruiting
Phase 3
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
Prostate Cancer Metastatic
University College, London3,360 enrolled18 locationsNCT06320067
Recruiting
Not Applicable
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
Intraprostatic Prostate Cancer
NYU Langone Health28 enrolled1 locationNCT07142967
Recruiting
Phase 2
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
Prostate Cancer
University of Chicago57 enrolled1 locationNCT05790213